Bangkok Dec-Con PCL maintains a strong liquidity position, with a current ratio of 1.24 and a low debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing. The company's liquidit…
BSTY.MC has a basic and diluted share count of 68,085,767, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of balance…
Charn Issara Development PCL has a liquidity ratio of 1.61, indicating a moderate ability to meet short-term obligations, supported by operating cash flow of 1,196,257,000 THB. However, the company…
Cord Blood Australia maintains a strong liquidity position, with a current ratio of 2.94, indicating that it holds nearly three times more current assets than current liabilities. The company's cas…
Charlotte's Web Holdings Inc operates with a debt-to-equity ratio of 0.92 and a current ratio of 3.48, indicating a moderate liquidity position with sufficient short-term assets to cover liabilitie…
InterCure Ltd maintains a capital structure characterized by significant leverage relative to its equity base, with long-term debt of ILS 183.0 million against total equity of ILS 396.5 million, re…
MACT.PSX maintains a relatively strong liquidity position, with a current ratio of 1.84, indicating the company can cover its short-term liabilities with its short-term assets. However, the company…
The company's capital structure is characterized by a debt-to-equity ratio of 0.29, indicating a relatively low level of leverage compared to industry norms. However, the company's liquidity positi…
Merchavia Holdings has a liquidity risk score of medium, with a current ratio of 0.3, indicating that its current liabilities significantly exceed its current assets. The company's liquidity positi…
Observe Medical operates with a capital structure that includes a debt-to-equity ratio of 1.03, indicating a moderate reliance on debt financing. The company's liquidity position is characterized b…
The company's capital structure is characterized by a high debt-to-equity ratio of 1.7, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a cur…
Shukra Pharmaceuticals Ltd maintains a strong liquidity position, with a current ratio of 3.79, indicating the company can cover its short-term liabilities more than three times over. The company's…
TISN.DH maintains a capital structure with a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with a…
URT.WA's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage profile. The company holds $1.46 million in cash and equivalents, while its tot…
The company's capital structure is characterized by a debt-to-equity ratio of 0.68, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Vaxil Bio Ltd maintains a pristine capital structure characterized by zero long-term debt and minimal liabilities relative to its asset base. The company reports total assets of 1,370,000 CAD again…
Wellgistics Health Inc has a negative equity position of $12.45 million and a total debt of $23.49 million, indicating a highly leveraged capital structure. The company's liquidity is constrained,…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 19.41, indicating a significant reliance on debt financing. Despite a negative net income of -80.89 million CNY,…
The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.31, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medi…
Anhui Huangshan Capsule Co Ltd maintains a strong liquidity position, with a current ratio of 3.13, indicating the company can cover its short-term liabilities more than three times over. However,…
Zhejiang Anglikang Pharmaceutical Co Ltd maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.38, indicating a moderate reliance on debt financing. The company's liqu…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position relative to its equity base. With total equity of KRW 146.3 billi…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position relative to its equity base. However, the company's liquidity pos…
The company maintains a relatively strong liquidity position, with a current ratio of 3.58, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, the com…
The company maintains a strong liquidity position, with a current ratio of 3.56, indicating that it has sufficient current assets to cover its current liabilities more than three times over. Howeve…
The company maintains a market capitalization of KRW 88.58 billion and a price-to-earnings ratio of 27.34, indicating a relatively high valuation compared to its earnings. Its price-to-book ratio o…
Health&Life Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.31, well below the industry median of 0.65. The company holds TWD 150.22 million in cash and equivalen…
ADBiotech's capital structure is highly leveraged, with a debt-to-equity ratio of 1.43, indicating that the company relies significantly on debt financing. The company's liquidity position is weak,…
Asanuma Corp's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively low reliance on debt financing. The company's liquidity position is assessed as medium,…
Tego Science Inc has a strong liquidity position, with a current ratio of 12.37, indicating that the company holds significantly more current assets than current liabilities. The company's cash and…
1947.HK maintains a strong liquidity position, with a current ratio of 2.15, indicating that it has more than double the current assets to cover its current liabilities. The company's cash and equi…
The company's capital structure is characterized by a debt-to-equity ratio of 0.9, indicating a relatively balanced mix of debt and equity financing. Its liquidity position is assessed as medium, w…
SLS Bio Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to KRW 1,557,440,350, which is significantly higher than its long-term debt of KRW 1,980,973,180. The compa…
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 41,154,584,840, which represents 26.45% of its total assets. Its liquidity FPT (free cash flow to total…
The company maintains a strong liquidity position, with a current ratio of 18.28, indicating a significant buffer of current assets over current liabilities. However, its free cash flow is negative…
The company's capital structure is characterized by a debt-to-equity ratio of 0.21, indicating a relatively conservative leverage position. However, the company reported negative operating and net…
PeopleBio Inc has a liquidity position that is relatively strong in terms of asset coverage, with a current ratio of 4.34, indicating that the company holds significantly more current assets than c…
The company maintains a debt-to-equity ratio of 0.8, indicating a relatively balanced capital structure with a moderate reliance on debt financing. Its liquidity position is characterized as medium…
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.21, indicating a conservative leverage position compared to industry norms. However, the company's liq…
SG HealthCare Co Ltd reported a revenue of 1,968,778,250 KRW in the latest period. Despite this, the company recorded a net loss of 612,978,520 KRW and an operating loss of 761,197,770 KRW, indicat…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥810.47 million, which is significantly higher than its total liabilities of ¥195.63 million, resulting in…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥1,799,816,000,000, which significantly exceeds its total liabilities of ¥151,211,000,000. This results in…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 6.19, indicating a significant reliance on debt financing. Its liquidity position is weak, as evidenced by a curr…
The company's capital structure shows a debt-to-equity ratio of 0.49, indicating a relatively conservative leverage position. However, the liquidity position is marked by a negative net cash positi…
The company maintains a strong liquidity position, with cash and equivalents amounting to $263.7 million, significantly exceeding its total liabilities of $93.1 million. The debt-to-equity ratio is…
6986.TWO has a strong liquidity position, with a current ratio of 9.75, indicating that the company holds significantly more current assets than current liabilities. The company's liquidity_fpt sco…
Shenzhen Neptunus Interlong Bio-technique Co Ltd reported a revenue of 280.33 million CNY and a net income of 1.93 million CNY in the latest financial period. The company's gross profit margin stan…
Adventa Bhd maintains a strong liquidity position, with a current ratio of 5.6, indicating that it holds significantly more current assets than current liabilities. However, the company reported ne…
Auro Laboratories has a debt-to-equity ratio of 0.63, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is assessed as medium, with a current rat…
Hai Duong Pharmaceutical Medical Material JSC has a debt-to-equity ratio of 0.6, indicating a relatively balanced capital structure with a moderate reliance on debt financing. The company's liquidi…
Global Pharmatech Inc has a current ratio of 6.72, indicating strong short-term liquidity, but its operating cash flow of -228,000 USD and negative net income of -274,000 USD suggest ongoing operat…
GOSS.TA maintains a capital structure with a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of…
Ikapharmindo Putramas Tbk PT has a debt-to-equity ratio of 0.61, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position…
Disc Medicine Inc maintains a conservative capital structure with total liabilities of $67.1 million against total equity of $740 million, resulting in a debt-to-equity ratio of 0.04. The balance s…
Kdventures AB exhibits a capital structure with a negligible debt-to-equity ratio of 0.0, indicating a nearly all-equity funded balance sheet. The company holds 23.91 million in cash and equivalent…
NUMI.TO's capital structure is highly leveraged, with a debt-to-equity ratio of 2.8, indicating significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a c…
Orion Pharma Ltd has a debt-to-equity ratio of 1.27, indicating a moderate reliance on debt financing, and a current ratio of 2.07, suggesting it has sufficient short-term assets to cover its short…
Peninsula Group Ltd exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 2.21, indicating a significant reliance on debt financing. The company's liquidity position is char…
Sigachi Industries Ltd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquidity position…
Sabaa International has a relatively conservative capital structure, with a debt-to-equity ratio of 0.24, indicating a low reliance on debt financing. The company's liquidity position is characteri…
SMS Pharmaceuticals Ltd maintains a debt-to-equity ratio of 0.49, indicating a relatively conservative capital structure. The company's liquidity position is assessed as medium, with a current rati…
ZEOX.PK exhibits a highly leveraged capital structure, with total liabilities of $2.95 billion and total equity of -$1.42 billion, resulting in a negative debt-to-equity ratio of -0.25. The company…
Berry Genomics maintains a capital structure with a debt-to-equity ratio of 0.09, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium…
Brother Enterprises Holding Co Ltd has a market capitalization of CNY 6.07 billion and an enterprise value to revenue ratio of 2.12, indicating a relatively low valuation compared to its revenue. T…
Green Cross Holdings has a debt-to-equity ratio of 1.49, indicating a relatively high level of leverage in its capital structure. The company's liquidity position is assessed as medium, with a curr…
CMG Pharmaceutical Co Ltd has a market price of 1,370 KRW per share, with a market capitalization of 202.54 billion KRW. The company's price-to-book ratio is 1.0, and its price-to-tangible-book rat…
Bioneer Corp maintains a relatively strong liquidity position, with cash and equivalents amounting to KRW 46,103,479,800, which is 28.8% of total assets. However, the company's long-term debt of KR…
The company's capital structure is characterized by a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Metacare Co Ltd maintains a strong liquidity position, with a current ratio of 14.43, indicating a significant buffer of current assets over current liabilities. The company's cash and equivalents…
Human Health Holdings Ltd has an equal number of basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities at present. However, the liquidity risk re…
PuraPharm Corp Ltd has a basic and diluted share count of 535,897,647 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However…
Boditech Med Inc maintains a strong liquidity position, with a current ratio of 5.51, indicating that the company has more than five times the current assets to cover its current liabilities. The c…
The company's capital structure is characterized by a debt-to-equity ratio of 0.87, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.14, indicating a conservative leverage position. However, the company's liquidity is assessed as mediu…
EOFlow's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as m…
Data Horizon Co Ltd has a market price of ¥639 per share, translating to a market capitalization of ¥8.11 billion. The company's price-to-book ratio is 2.32, and its price-to-tangible-book ratio is…
Town Health International Medical Group Ltd has a market capitalization of HKD 1.46 billion and a price-to-earnings ratio of 101.29, indicating a high valuation relative to its earnings. The compan…
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 25,511,878,170, significantly exceeding its total liabilities of KRW 15,942,556,870. The liquidity FPT…
The company maintains a market capitalization of ¥2.12 billion and a price-to-earnings ratio of 47.05, indicating a relatively high valuation relative to earnings. Its liquidity position is charact…
The company exhibits a strong liquidity position, with a current ratio of 23.43, indicating a significant excess of current assets over current liabilities. The price-to-book ratio of 12.78 suggest…
Chiome Bioscience Inc has a strong liquidity position, with cash and equivalents amounting to ¥13,252,590,000, significantly exceeding its total liabilities of ¥506,367,000, as reflected in a curre…
Bionime Corp's capital structure is characterized by a high debt-to-equity ratio of 1.49, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium…
The company maintains a strong liquidity position, with a current ratio of 2.45 and cash and equivalents amounting to TWD 132,018,000. Its debt-to-equity ratio is 0.01, indicating a conservative ca…
The company's capital structure is characterized by a debt-to-equity ratio of 0.57, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.33, indicating a conservative leverage position relative to its equity base. With cash and equivalents amounting…
The company's capital structure is characterized by a low level of dilution, with basic and diluted shares outstanding being equal at 2,032,890,585 shares. The market capitalization is 382,183,429…
The company maintains a market price of TWD 68.3, with a market capitalization of TWD 1.85 billion, and a price-to-earnings ratio of 12.69, which is relatively low compared to the industry median.…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage position relative to industry norms. With a current ratio of 13.97, the fi…
The company's capital structure is characterized by a high proportion of equity, with total equity of TWD 907.28 million and total liabilities of TWD 43.66 million, resulting in a debt-to-equity ra…
The company maintains a strong liquidity position, with cash and equivalents amounting to TWD 115 million, representing 17.35% of total assets. The current ratio of 27.43 indicates a highly liquid…
WeLeader Biomedical has a market capitalization of TWD 3,047,093,000 and a price-to-earnings ratio of 68.89, indicating a high valuation relative to its earnings. The company's price-to-book ratio…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.18, indicating a conservative leverage position relative to its equity base of $41.27 million. Its liquidity posi…
Kintor Pharmaceutical Ltd operates with a capital structure that includes total liabilities of CNY 1.58 billion and total equity of CNY 1.83 billion, resulting in a debt-to-equity ratio of 0.47. Th…
ABERA.TE has a current ratio of 2.73, indicating that it holds 2.73 times more current assets than current liabilities, which suggests a relatively strong short-term liquidity position. However, th…
ACCN.NS maintains a strong liquidity position with a current ratio of 5.08, indicating that its current assets significantly exceed its current liabilities. The company's liquidity_fpt metric shows…
AHC.BK maintains a strong liquidity position, with a current ratio of 5.89, indicating a significant buffer of current assets over current liabilities. The company's liquidity is further supported…
Allmed Solutions Ltd has a capital structure with 100,020,803 basic and diluted shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remain…
BMX.WA has a market capitalization of $45.79 million and an enterprise value to revenue ratio of 0.93, indicating a relatively low valuation compared to its revenue. The company's liquidity positio…
COSP.WA's capital structure is characterized by a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position. However, the company's liquidity is rated as medium, with a c…
Covance operates with a strong liquidity position, as evidenced by a current ratio of 5.94, indicating that current assets significantly exceed current liabilities. The company holds $5.71 billion…
EPIC.CD maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium, wit…
GRIN.CD's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company holds $11,371,830 in cash and equivalents, but this is…
Gland Pharma maintains a strong capital structure with a debt-to-equity ratio of 0.12, indicating a conservative leverage position relative to its equity base. The company's liquidity is assessed a…
Hayat Pharmaceutical Industries Company PSC maintains a strong liquidity position, with a current ratio of 4.79, indicating that it has more than four times the current assets to cover its current…
Healthy Extracts Inc operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of 7.27, indicating that the company is financed predominantly through debt. The comp…
INTI.PK has a negative equity position of -$1,291,910, indicating a significant deficit in its capital structure. The company's liquidity is supported by $2,375,490 in cash and equivalents, which i…
KROS.NS maintains a strong liquidity position, with a current ratio of 3.21, indicating the company can easily cover its short-term liabilities with its current assets. The company also holds INR 8…
Nanexa AB's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative approach to leverage. However, the company's liquidity position is assessed as medium…
NURE.NS exhibits a strong capital structure with a debt-to-equity ratio of 0.03, indicating minimal leverage and a conservative financing approach. The company's liquidity position is characterized…
The company's capital structure is characterized by a debt-to-equity ratio of 0.77, indicating a moderate reliance on debt financing relative to equity. However, the liquidity position is weak, as…
OPTI.CD's capital structure is characterized by a debt-to-equity ratio of 0.99, indicating a relatively balanced mix of debt and equity financing. However, the company's liquidity position is weak,…
Ortivus AB has a liquidity position that is marginally balanced, with a current ratio of 0.98, indicating that its current liabilities slightly exceed its current assets. The company's liquidity is…
PRLD.NGM has a strong liquidity position, as evidenced by a current ratio of 2.4, indicating that the company has more than twice the current assets to cover its current liabilities. The company's…
SMD Rise PCL exhibits a strong liquidity position, with a current ratio of 7.6, indicating the company can easily cover its short-term liabilities with its current assets. The company holds cash an…
The company maintains a strong liquidity position, with a current ratio of 5.33, indicating that it has more than five times the current assets to cover its current liabilities. Its cash and equiva…
TDMS.KL maintains a debt-to-equity ratio of 0.86, indicating a moderate level of leverage, while its current ratio of 1.09 suggests limited short-term liquidity cushion. The company's free cash flo…
Structure and Liquidity VIP Gloves Ltd exhibits a highly leveraged capital structure, with total liabilities of AUD 4,258,340 and total equity of -AUD 3,551,910, resulting in a negative net worth.…
ViroGates A/S maintains a strong liquidity position, with cash and equivalents amounting to DKK 12.23 million, which significantly exceeds its total liabilities of DKK 6.77 million, resulting in a…
VM.V's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage position. The company holds $267,050.0 in cash and equivalents, but its operating…
The company maintains a relatively low price-to-book ratio of 0.44, indicating that the market values the company's equity at a discount to its book value. The price-to-tangible-book ratio is also…
Northeast Pharmaceutical Group maintains a conservative capital structure with a debt-to-equity ratio of 0.45 and a current ratio of 1.15. The balance sheet shows total assets of 12.89 billion CNY…
The company's capital structure is characterized by a relatively low debt-to-equity ratio of 0.15, indicating a conservative leverage position compared to industry norms. However, the company's liq…
Guangdong Jiaying Pharmaceutical Co Ltd maintains a strong liquidity position, with cash and equivalents amounting to CNY 49,482,400, which significantly exceeds its total liabilities of CNY 62,021…
Luoxin Pharmaceuticals has a market capitalization of 4.75 billion CNY and a price-to-book ratio of 2.08, indicating that the market values the company at a premium to its book value. The company's…
Tiansheng Pharmaceutical Group Co Ltd has a debt-to-equity ratio of 0.23, indicating a relatively conservative capital structure. However, the company reported negative net cash after subtracting t…
Jin Yang Pharmaceutical Co Ltd maintains a relatively strong liquidity position, with a current ratio of 1.85, indicating that it has sufficient current assets to cover its current liabilities. How…
Sinil Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 5.63, indicating that it has more than five times the current assets to cover its current liabilities. The…
The company's capital structure is highly leveraged, with total liabilities of $7.21 billion and total equity of -$6.64 billion, indicating a negative net worth. Liquidity is constrained, as eviden…
The company maintains a strong liquidity position, with cash and equivalents amounting to KRW 26,455,983,070, which represents a significant portion of its total assets of KRW 84,178,004,620. The l…
JW Holdings Corp maintains a capital structure with a debt-to-equity ratio of 1.35, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a…
Kingworld Medicines Group Ltd has a basic and diluted share count of 622.5 million shares, indicating no immediate dilution pressure from share issuance. However, the company's liquidity risk could…
The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.39, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medi…
The company's capital structure is characterized by a debt-to-equity ratio of 0.43, indicating a relatively conservative use of debt financing. However, the company's liquidity position is concerni…
The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.27, indicating a relatively low reliance on debt financing. Its liquidity position is assessed as medium, wi…
1652.HK has a liquidity position that is below the typical threshold for financial health, with a current ratio of 0.56, indicating that the company's current assets are insufficient to cover its c…
Gaush Meditech Ltd has a fully diluted share count of 147,887,869 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible i…
Korea Arlico Pharm Co Ltd has a market price of 3,180 KRW per share, with a market capitalization of 47.74 billion KRW. The company's price-to-book ratio is 0.56, and its price-to-tangible-book rat…
Beijing Beilu Pharmaceutical Co Ltd maintains a relatively strong liquidity position, with a current ratio of 2.4, indicating that it has 2.4 times more current assets than current liabilities. How…
The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.1, indicating a low reliance on debt financing. Its liquidity position is characterized as medium, with a cu…
Wuhan Hiteck Biological Pharma Co Ltd has a market price of 29.46 CNY per share, with a market capitalization of 3.86 billion CNY. The company's price-to-book ratio is 1.78, and its price-to-tangib…
308080.KQ has a current ratio of 20.04, indicating strong liquidity, but its debt-to-equity ratio of 0.17 suggests a relatively low level of leverage. The company's liquidity position is further su…
The company's capital structure is characterized by a debt-to-equity ratio of 0.37, indicating a relatively conservative leverage position compared to the industry median of 0.52. However, its liqu…
The company's capital structure is characterized by a debt-to-equity ratio of 0.19, indicating a relatively low reliance on debt financing. However, the company's liquidity position is assessed as…
The company's capital structure is characterized by a debt-to-equity ratio of 0.52, indicating a moderate level of leverage. Its liquidity position is marked by a current ratio of 1.08, suggesting…
The company's capital structure is characterized by a high proportion of equity, with total equity of KRW 10,612,635,480 and total liabilities of KRW 2,854,083,540, resulting in a debt-to-equity ra…
The company maintains a strong liquidity position, with a current ratio of 4.0, indicating that it has four times more current assets than current liabilities. However, its free cash flow is negati…
The company's capital structure is characterized by a high debt-to-equity ratio of 1.77, indicating a significant reliance on debt financing. Its liquidity position is assessed as medium, with a cu…
6637.TWO maintains a relatively strong liquidity position, with a current ratio of 3.04, indicating that it has sufficient current assets to cover its current liabilities. However, the company's op…
6879.TWO maintains a strong liquidity position, with a current ratio of 9.27 and cash and equivalents amounting to TWD 250,687,000. The company's liquidity FPT (free cash flow to total liabilities)…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.